Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Doherty

Showing results (711-720 of 744) with videos related to

Pageof 75
Sort By:
Human Vaccines & Immunotherapeutics|March 14, 2018
Safety study of live, oral human rotavirus vaccine: A cohort study in United States health insurance plansVeena Hoffman, Remon Abu-Elyazeed, Cheryl Enger, et al.
The Medical Journal of Australia|August 29, 2014
Open letter to the Hon Tony Abbott MPAnthony J McMichael, Stephen R Leeder, Bruce K Armstrong, et al.
Toxicology in Vitro : an International Journal Published in Association with BIBRA|May 21, 2018
Inflammatory response following in vitro exposure to methylmercury with and without n-3 long chain polyunsaturated fatty acids in peripheral blood mononuclear cells from systemic lupus erythematosus patients compared to healthy controlsWilliam Crowe, Philip J Allsopp, Jennifer F Nyland, et al.
Nature|April 18, 1996
Lack of IL-4-induced Th2 response and IgE class switching in mice with disrupted Stat6 geneK Shimoda, J van Deursen, M Y Sangster, et al.
Nature Immunology|October 22, 2013
The kinase mTOR modulates the antibody response to provide cross-protective immunity to lethal infection with influenza virusRachael Keating, Tomer Hertz, Marie Wehenkel, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 15, 1996
Recombinant polyepitope vaccines for the delivery of multiple CD8 cytotoxic T cell epitopesS A Thomson, S L Elliott, M A Sherritt, et al.
Mbio|October 29, 2015
Inactivated Influenza Vaccine That Provides Rapid, Innate-Immune-System-Mediated Protection and Subsequent Long-Term Adaptive ImmunityBrendon Y Chua, Chinn Yi Wong, Edin J Mifsud, et al.
Nature Immunology|March 26, 2013
Receptor interacting protein kinase 2-mediated mitophagy regulates inflammasome activation during virus infectionChristopher Lupfer, Paul G Thomas, Paras K Anand, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 10, 2010
Constraints within major histocompatibility complex class I restricted peptides: presentation and consequences for T-cell recognitionAlex Theodossis, Carole Guillonneau, Andrew Welland, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 2, 2016
Molecular basis for universal HLA-A*0201-restricted CD8+ T-cell immunity against influenza virusesSophie A Valkenburg, Tracy M Josephs, E Bridie Clemens, et al.
Pageof 75

Showing results (711-720 of 744) with videos related to

Sort By:
Pageof 75
Human Vaccines & Immunotherapeutics|March 14, 2018
Safety study of live, oral human rotavirus vaccine: A cohort study in United States health insurance plansVeena Hoffman, Remon Abu-Elyazeed, Cheryl Enger, et al.
The Medical Journal of Australia|August 29, 2014
Open letter to the Hon Tony Abbott MPAnthony J McMichael, Stephen R Leeder, Bruce K Armstrong, et al.
Toxicology in Vitro : an International Journal Published in Association with BIBRA|May 21, 2018
Inflammatory response following in vitro exposure to methylmercury with and without n-3 long chain polyunsaturated fatty acids in peripheral blood mononuclear cells from systemic lupus erythematosus patients compared to healthy controlsWilliam Crowe, Philip J Allsopp, Jennifer F Nyland, et al.
Nature|April 18, 1996
Lack of IL-4-induced Th2 response and IgE class switching in mice with disrupted Stat6 geneK Shimoda, J van Deursen, M Y Sangster, et al.
Nature Immunology|October 22, 2013
The kinase mTOR modulates the antibody response to provide cross-protective immunity to lethal infection with influenza virusRachael Keating, Tomer Hertz, Marie Wehenkel, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 15, 1996
Recombinant polyepitope vaccines for the delivery of multiple CD8 cytotoxic T cell epitopesS A Thomson, S L Elliott, M A Sherritt, et al.
Mbio|October 29, 2015
Inactivated Influenza Vaccine That Provides Rapid, Innate-Immune-System-Mediated Protection and Subsequent Long-Term Adaptive ImmunityBrendon Y Chua, Chinn Yi Wong, Edin J Mifsud, et al.
Nature Immunology|March 26, 2013
Receptor interacting protein kinase 2-mediated mitophagy regulates inflammasome activation during virus infectionChristopher Lupfer, Paul G Thomas, Paras K Anand, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 10, 2010
Constraints within major histocompatibility complex class I restricted peptides: presentation and consequences for T-cell recognitionAlex Theodossis, Carole Guillonneau, Andrew Welland, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 2, 2016
Molecular basis for universal HLA-A*0201-restricted CD8+ T-cell immunity against influenza virusesSophie A Valkenburg, Tracy M Josephs, E Bridie Clemens, et al.
Pageof 75